David Whellan
Cardiovascular Disease · Philadelphia, PANPI 1184647794
Payments from drug & device makers
Across 75 payments — averaging $2692.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cvrx, Inc.$74K
- Novartis$58K
- Resmed Corp$42K
- Amgen$18K
- Merck$5K
- Amryt Pharma Holdings Ltd$2K
- plus $2K from 5 others
Across 4 payments — averaging $2258.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$5K
- Novo Nordisk$5K
What the payments were for
- Consulting fees$75,62597%
- Travel & lodging$1,8182%
- Food & beverage$4091%
- Education$350%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cvrx, Inc. | 29 | $74,463 |
| Novartis | 8 | $58,265 |
| Resmed Corp | 1 | $41,750 |
| Amgen | 18 | $18,120 |
| Merck | 3 | $5,418 |
| Amryt Pharma Holdings Ltd | 11 | $1,952 |
| Novo Nordisk | 1 | $1,163 |
| Aegerion Pharmaceuticals, Inc. | 1 | $750 |
| Alnylam Pharmaceuticals Inc. | 1 | $35 |
| AstraZeneca | 1 | $22 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barostim Neo System$74,463
- RYBELSUS$1,163
- ENTRESTO$495
How this compares
$201,950 in reported general payments places this provider in the 90th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Other cardiovascular disease in Philadelphia
- Danielle DuffyPhiladelphia$29.5M
- Brian DrachmanPhiladelphia$3.8M
- Bonnie KyPhiladelphia$1.9M
- Marielle Scherrer CrosbiePhiladelphia$1.6M
- Paul ForfiaPhiladelphia$1.2M
- Quang BuiPhiladelphia$933K
- Leandro Slipczuk BustamantePhiladelphia$638K
- William MatthaiPhiladelphia$542K
- Dean KaralisPhiladelphia$463K
- Nehal MehtaPhiladelphia$419K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.